These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8845588)

  • 1. Anti-amyloid drugs: potential in the treatment of diseases associated with aging.
    Kisilevsky R
    Drugs Aging; 1996 Feb; 8(2):75-83. PubMed ID: 8845588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: implications for Alzheimer's disease.
    Kisilevsky R; Lemieux LJ; Fraser PE; Kong X; Hultin PG; Szarek WA
    Nat Med; 1995 Feb; 1(2):143-8. PubMed ID: 7585011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparan sulfate as a therapeutic target in amyloidogenesis: prospects and possible complications.
    Kisilevsky R; Ancsin JB; Szarek WA; Petanceska S
    Amyloid; 2007 Mar; 14(1):21-32. PubMed ID: 17453622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteoglycans and amyloid fibrillogenesis.
    Kisilevsky R; Fraser P
    Ciba Found Symp; 1996; 199():58-67; discussion 68-72, 90-103. PubMed ID: 8915604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic strategies for human amyloid diseases.
    Sacchettini JC; Kelly JW
    Nat Rev Drug Discov; 2002 Apr; 1(4):267-75. PubMed ID: 12120278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colchicine analogues: effect on amyloidogenesis in a murine model and, in vitro, on polymorphonuclear leukocytes.
    Wolach B; Gotfried M; Jedeikin A; Lishner M; Brossi A; Ravid M
    Eur J Clin Invest; 1992 Sep; 22(9):630-4. PubMed ID: 1459179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A beta amyloidogenesis: unique, or variation on a systemic theme?
    Kisilevsky R; Fraser PE
    Crit Rev Biochem Mol Biol; 1997; 32(5):361-404. PubMed ID: 9383610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel pharmacological strategies in amyloidosis.
    Lachmann HJ; Hawkins PN
    Nephron Clin Pract; 2003; 94(4):c85-8. PubMed ID: 12972717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis, diagnosis and treatment of systemic amyloidosis.
    Pepys MB
    Philos Trans R Soc Lond B Biol Sci; 2001 Feb; 356(1406):203-10; discussion 210-1. PubMed ID: 11260801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Living kidney transplantation between brothers with unrecognized renal amyloidosis as the first manifestation of familial Mediterranean fever: a case report.
    Peces R; Afonso S; Peces C; Nevado J; Selgas R
    BMC Med Genet; 2017 Aug; 18(1):97. PubMed ID: 28859624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloidosis.
    Pinney JH; Hawkins PN
    Ann Clin Biochem; 2012 May; 49(Pt 3):229-41. PubMed ID: 22402917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary bladder amyloidosis with familial Mediterranean fever in a living donor kidney transplant recipient: a case report.
    Imamura S; Narita S; Nishikomori R; Tsuruta H; Numakura K; Maeno A; Saito M; Inoue T; Tsuchiya N; Nanjo H; Heike T; Satoh S; Habuchi T
    BMC Res Notes; 2016 Oct; 9(1):473. PubMed ID: 27760547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in amyloidosis.
    Cohen AS; Jones LA
    Curr Opin Rheumatol; 1993 Jan; 5(1):62-76. PubMed ID: 8435291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colchicine use in isolated renal AA amyloidosis.
    Meneses CF; Egües CA; Uriarte M; Belzunegui J; Rezola M
    Reumatol Clin; 2015; 11(4):242-3. PubMed ID: 25453598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current and emerging views and treatments of systemic immunoglobulin light-chain (Al) amyloidosis.
    Comenzo RL
    Contrib Nephrol; 2007; 153():195-210. PubMed ID: 17075231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of perlecan gene expression precedes amyloid formation during experimental murine AA amyloidogenesis.
    Ailles L; Kisilevsky R; Young ID
    Lab Invest; 1993 Oct; 69(4):443-8. PubMed ID: 8231112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic amyloidosis.
    Lachmann HJ; Hawkins PN
    Curr Opin Pharmacol; 2006 Apr; 6(2):214-20. PubMed ID: 16483845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary glycosaminoglycan levels as a marker of renal amyloidosis in patients with familial Mediterranean fever.
    Nadir H; Unver S; Ozel AM; Yazgan Y; Gultepe M; Evrenkaya TR; Demirturk L; Gurbuz AK
    Ren Fail; 2007; 29(1):73-7. PubMed ID: 17365913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Amyloidosis].
    Franklin EC
    Fortschr Med; 1977 May; 95(20):1329-32. PubMed ID: 406184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the second phase of amyloidogenesis in a mouse model by a single-dose colchicine regimen.
    Shtrasburg S; Pras M; Gal R; Salai M; Livneh A
    J Lab Clin Med; 2001 Aug; 138(2):107-11. PubMed ID: 11477377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.